Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

August 23, 2019
Otsuka Pharmaceutical

UL·OS Men's Skincare Brand Renewal Launch of Three Moisturizing Products
August 22, 2019
Otsuka Holdings

Otsuka Group Adopts CO2-free Electricity Annual CO2 Emissions to Decline by Approximately 9%
August 22, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical Obtains Additional Indication of Gastric Cancer in Japan for Its Anticancer Agent LONSURF®
August 19, 2019
Otsuka Pharmaceutical

Otsuka Pharmaceutical Participates in Summer Events in Tokushima, Japan Exciting Summer in WAJIKI, Tokushima Awa Odori, Oronamin C Drink PRESENTS Awa Odori Sound Festival
July 30, 2019
Otsuka Holdings

Notice concerning amendments to the forecasts for the first half of FY2019
July 29, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical to Participate in READYFOR SDGs, Using Crowd Funding to Support Organizations Addressing Issues in the Field of Oncology
July 29, 2019
Taiho Pharmaceutical

CHMP Issues Positive Opinion for LONSURF® (trifluridine/tipiracil) in Previously Treated Metastatic Gastric Cancer
July 22, 2019
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Comprehensive Cooperative Agreement with Nagano Prefecture
June 28, 2019
Otsuka Pharmaceutical

POCARI SWEAT Marketing Wins Top Prize at Japan Marketing Awards
June 28, 2019
Otsuka Pharmaceutical

Deliciously Illustrated SketchCook Wins in Three Categories at PR Awards Asia 2019 ― Dietary education app promotes awareness about the importance of meals and nutrition to children―
June 18, 2019
Otsuka Holdings Other

Otsuka Electronics Announces Personnel Changes
June 10, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical Forms Japan-based Corporate Venture Capital Firm to Foster Healthcare Startups in Japan
June 7, 2019
Taiho Pharmaceutical

Otsuka and Taiho Announce that Taiho Will Commercialize Two of Astex Pharmaceuticals’ Drug Candidates in North America
June 7, 2019
Otsuka Pharmaceutical Taiho Pharmaceutical

Otsuka and Taiho Announce that Taiho Will Commercialize Two of Astex Pharmaceuticals' Drug Candidates in North America
June 7, 2019
Otsuka Pharmaceutical

Otsuka and its Subsidiary Astex Pharmaceuticals, Inc. Announce Positive Results from a Phase III Clinical Trial of Anticancer Candidate ASTX727
May 30, 2019
Otsuka Holdings

Otsuka Announces the Third Medium-Term Management Plan: Achieving Sustainable Growth
May 22, 2019
Otsuka Pharmaceutical

Otsuka and Japan Kidney Association to Collaborative on Autosomal Dominant Polycystic Kidney Disease
May 20, 2019
Otsuka Holdings

Notice Concerning Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
May 10, 2019
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory concludes a comprehensive collaborative agreement with Naruto City (Tokushima) on creating a community where citizens can live a safe, healthy life
April 18, 2019
Otsuka Pharmaceutical

Erdafitinib Receives Regulatory Approval in U.S.
April 15, 2019
Otsuka Holdings

Notice Regarding Company Split (Simplified Absorption–type Company Split)
April 12, 2019
Otsuka Holdings

Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation
April 12, 2019
Otsuka Pharmaceutical

EQUELLE: Dietary Supplement to Support Women's Health Expansion of US business through launch of sales via D-to-C channel
April 8, 2019
Otsuka Pharmaceutical

Otsuka Pharmaceutical Establishes Health Beverage Subsidiary in Myanmar
March 28, 2019
Otsuka Holdings

Otsuka Holdings appoints Board Members and Audit & Supervisory Board Members
March 28, 2019
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Sponsor 30th Southeast Asian Games 2019 (Philippines)
March 25, 2019
Otsuka Holdings Otsuka Pharmaceutical

Otsuka’s Subsidiary Avanir Pharmaceuticals Reports Phase 3 Data Evaluating Investigational AVP-786 for the Treatment of Moderate-to-Severe Agitation in Patients with Alzheimer’s Dementia
March 25, 2019
Otsuka Pharmaceutical

Otsuka's Subsidiary Avanir Pharmaceuticals Reports Phase 3 Data Evaluating Investigational AVP-786 for the Treatment of Moderate-to-Severe Agitation in Patients with Alzheimer's Dementia
March 12, 2019
Otsuka Foods

Otsuka Foods Announces Appointment of Executive Officers
March 11, 2019
Otsuka Holdings Otsuka Chemical

Otsuka Chemical Announces Personnel Changes